Abstract
Introduction
One of the transcription factors crucial for normal myeloid cell development is the CCAAT/enhancer binding protein alpha (CEBPA) [1] [2] [3] [4] [5] . Targeted disruption of CEBPA results in a block of granulocyte maturation [6] , whereas expression of CEBPA in precursor cells is sufficient to trigger granulocytic differentiation [7] . In AML patients, deregulation of CEBPA function is a common event comprising genomic mutations [8] [9] [10] , transcriptional suppression [11] and functional inactivation [12, 13] . Furthermore, CEBPA protein is suppressed in chronic myeloid leukaemia in blast crisis by the poly(rC)-binding protein hnRNP E2 [14] . Finally, the RNA-binding protein calreticulin can be specifically induced in core binding factor AML [15, 16] . [17, 18] . If homeostasis cannot be achieved cell death is triggered [19, 20] [21] . In the case of IRE1, ER-stress induces the cleavage of the X-box binding protein 1 (XBP1) mRNA encoding a novel potent transcriptional activator of UPR target genes [22] [23] [24] [25] . Other cellular targets of the UPR are calreticulin, CHOP and GRP78. In [27] [28] [29] [30] . We identified YY1, the nuclear 
The unfolded protein response (UPR) is triggered by the accumulation of misfolded proteins in the endoplasmic reticulum (ER). It reduces the protein load entering the ER by lowering the global protein synthesis and by increasing the capacity to handle misfolded proteins through activation of ER chaperone molecules

. Three pathways of ER-stress transduction have been identified comprising the inositol-requiring protein-1 (IRE1), the activating transcription factor 6 (ATF6) and the protein kinase RNA-like ER kinase (PERK)
this report, we found that the UPR is activated in 17.4% of AML patients as determined by the induction of the XBP1 spliced variant and increased expression of GRP78 and calreticulin. At the molecular level, we found that the activation of the calreticulin promoter following ER-stress was mediated by two copies of an ER-stress response element (ERSE)
Materials and methods
Patients
Conditional calreticulin expression in myeloid cells
The U937-T cell line was kindly provided by Gerard Grosveld ( 
Constructs
The human HA-tagged ATF6 plasmid was provided by Ron Prywes [32] . The plasmid for the nuclear form of human ATF6n was a gift from Katzutoshi Mori [23] . The plasmid for YY1 was from Yang Shi [33] [15, 34] .
Results
The XBP1 spliced variant (XBP1s) is expressed in a subset of AML patients Fig. 2D (Fig. 3C) , and for ERSE2 into the -205 nt construct (Fig. 3D) . We found that activation following ER-stress was completely abolished when the CAAT motifs of both ERSE1 and ERSE2 were mutated (construct M4 in Fig. 3C (Fig. 3D) 
hrs of UPR inducing treatment in Hela cells (Fig. 2B). Results were similar for three different UPR inducing compounds (A23187, thapsigargin and tunicamycin). After 16 hrs, the mean increase of calreticulin mRNA was 2.5-fold (SD Ϯ 1.1) in K562 cells (Fig. 2C) and 4.1-fold (SD Ϯ 1.1) in Hela cells (Fig. 2B). The induction of calreticulin protein in K562 cells following UPR activation is depicted in
ATF6n activates the calreticulin promoter through both ERSE1 and ERSE2
The nuclear form of ATF6 orchestrates the induction of target genes during the UPR [35] activation. We transfected various constructs of the calreticulin promoter together with a plasmid encoding human ATF6n into U937 cells (Fig. 3E, F, G) . We found that ATF6n activated the -298 nt construct up to 6.2-fold. ATF6n-mediated activation again showed a two-step pattern (Fig. 3E) . Specific mutation of the CAAT motifs in both ERSE1 and ERSE2 (M4) completely abolished ATF6n-mediated activation (Fig. 3F) . [30, 35] Fig. 4B 
Mutation of the putative binding site for ATF6 in ERSE1 (M2) reduced the activating potential to that observed for ERSE2 alone. Mutation of the putative YY1-binding site in ERSE1 (M3), again, had no effect on ATF6n-mediated activation. In contrast, mutation of the YY1 site in ERSE2 (M6) abolished ATF6n-mediated activation of ERSE 2 (Fig. 3G). XBP1s and TFII-I, transcription factors reported to activate promoters through ERSE motifs, failed to affect ATF6n-mediated activation (data not shown). These results indicate that the two ERSE sequences of the calreticulin promoter are targeted by ATF6, by at least one CAAT binding protein, and (at least for ERSE2) by YY1.
YY1 is required for ATF6 binding to ERSE 2, but not to ERSE 1 of the calreticulin promoter
We performed EMSA in H1299 cells to identify the factors binding to the two ERSE motifs. We observed two binding activities (complex 1 and 2) in each motif (Fig. 4A). Analyses with specific antibodies identified complex 1 as YY1 (lanes 7 and 16 in Fig. 4A), and complex 2 as NFYA, the DNA-binding subunit of the tripartite transcription factor NFY (lanes 3 and 12). Specific mutations of © 2009 The Authors Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 ER-stress induces XBP1 mRNA splicing and calreticulin expression. (A) Adherent Hela and leukaemic K562 cells were treated with thapsigargin (300nM). The spliced (S) and unspliced (U) form of XBP1 mRNA were detected by RT-PCR. (B) Calreticulin mRNA was induced in Hela cells after treatment with the ER-stress inducing agents A23187 at 7 M, thapsigargin 300 nM or tunicamycin 5 g/ml. Relative expression levels of calreticulin were measured by quantitative RT-PCR and normalized to 7s RNA. (C) Treatment of K562 cells with thapsigargin (300nM) increased expression of calreticulin mRNA. Each experiment was repeated at least three times. Mean values and standard deviation (SD, error bars) are depicted. (D) Western blot analyses for calreticulin, GRP78, CHOP, the nuclear form of ATF6 (ATF6n) and CUGBP1 (as negative control) is shown using cytoplasmic (CP, upper panel) and nuclear (NE, lower panel) protein fractions of K562 cells treated with 300 nM thapsigargin. Actin and Sp1 protein served as loading control. the CAAT-motif (M1 in ERSE 1 and M5 in ERSE 2) abolished NFYA binding, and no binding activity of complex 2 was observed with mutations of the YY1-binding site (M3 in ERSE 1 and M6 in ERSE 2). These results suggest that both NFYA and YY1 are directly binding to both ERSE sequences. The demonstration of ATF6 binding by EMSA is technically challenging
. Using nuclear extracts from H1299 cells transfected with the expression plasmid encoding ATF6n, a third complex was detectable binding to both ERSE motifs of the calreticulin promoter (Figs. 4B and C). The addition of a specific antibody against ATF6 shifted complex 3 in ERSE 1 (lane 4 in
Fig. 3 Two ERSE mediate induction of calreticulin by ATF6 following ER-stress. (A, C and D) Myeloid U937 cells were treated with thapsigargin (300 nM) starting 8 hrs after transfection. After 16 hrs, cells were harvested. Each transfection experiment was repeated at least three times. (A) Using promoter deletion constructs, two ERSE motifs (ERSE1 and ERSE2) were identified. Fold induction was the ratio of activity compared to cells treated with DMSO (carrier) alone. Mean values and SD (error bars) are depicted. (B) Schematic presentation of both ERSE motifs (ERSE1 and ERSE2). M1 to M8 encode mutations within a fragment of the calreticulin promoter cloned into the pGl3 luciferase vector. (C) Mutations of the binding sites of NFY (M1) and ATF6n (M2), but not YY1 (M3) within ERSE1 reduced activation of the calreticulin promoter following ER-stress. M4 indicates mutations of both NFY sites. (D) Mutations of the binding sites for NFY (M5), YY1 (M6) or deletion of 2 bp between the two sites (M8) decreased the activation of the ERSE2 motif. (E-G) U937 cells were transfected with pCMV-ATF6-373 (ATF6n) or pCMV empty vector. (E) Calreticulin promoter deletion constructs transfected together with ATF6n led to the identification of two ATF6n responsive elements. (F) Mutations of the binding sites of NFY (M1) or ATF6n (M2), but not of YY1 (M3) affected the activation of ERSE1 by ATF6. (G) Mutating the binding sites of NFY (M5) or YY1 (M6), as well as a 2 bp deletion between these sites (M8) led to the complete loss of ERSE2 activation by ATF6. The exchange of 2 bp between these sites (M7) had no effect.
NFYA, YY1 and ATF6 binding to the calreticulin promoter is activated after induction of ER-stress
In order to assess changes in transcription factor binding to the ERSE sequences following induction of ER-stress, we performed chromatin immunoprecipitation experiments (Fig. 5) 
Conditional expression of calreticulin in myeloid cells suppresses CEBPA translation
We have reported that calreticulin in vitro leads to a translational block of the myeloid key transcription factor CEBPA through enhanced binding to a stem loop structure within the CEBPA mRNA [15] . To Figure 3B . (Fig. 6A) . In contrast, CEBPA mRNA remained unchanged (Fig. 6B) 
(A) In nuclear extracts from H1299 cells, two complexes (C1-2) were detectable by EMSA. In M1 and M5, the binding sites for NFY are mutated. M3 and M6 indicate mutations of the YY1-binding sites. 'cold' ϭ unlabeled oligo. (B) Nuclear extracts (NE) from H1299 cells were transfected with ATF6n. Three complexes (C1-3) binding to ERSE1 were detectable. M2 indicates mutation of the ATF6 binding site. The NFY site is mutated in M1, and YY1 binding is blocked by mutant M3. (C) Incubating NE with an oligonucleotide encoding ERSE2 led to the formation of three complexes (C1-3). The addition of ATF6 antibody abolished complex 3. Mutations of the NFY (M5) or the YY1 (M6) binding site or a 2 bp deletion between the NFY and YY1 binding sites (M8) also abrogated complex 3. M7 indicates the mutation of 2 bp within the NFY and YY1 binding site (M7).
